Document:

Exhibit
10.114

 

REGISTRATION
RIGHTS AGREEMENT

 

This
Registration Rights AGREEMENT (the “Agreement”), dated as of
June 8, 2020 (the “Execution Date”), is entered into by and between CLEAN ENERGY TECHNOLOGIES, INC.,
a Nevada corporation with its principal executive office at 2990 Redhill Ave, Costa Mesa, California 92626 (the “Company”),
and GHS Investments LLC, a Nevada limited liability company, with offices at 420 Jericho Turnpike, Suite 102 Jericho, NY
11753 (the “Investor”).

 

RECITALS:

 

Whereas,
pursuant to the Equity Financing Agreement entered into by and between the Company and the Investor of even date (the “Equity
Financing Agreement”), the Company has agreed to issue and sell to the Investor an indeterminate number of shares of
the Company’s common stock, par value $0.001 per share (the “Common Stock”), up to an aggregate purchase
price of Two Million Dollars($2,000,000);

 

Whereas,
as an inducement to the Investor to execute and deliver the Equity Financing Agreement, the Company has agreed to provide certain
registration rights under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor
statute (collectively, the “1933 Act”), and applicable state securities laws, with respect to the shares of
Common Stock issuable pursuant to the Equity Financing Agreement.

 

Now
therefore, in consideration of the foregoing
promises and the mutual covenants contained hereinafter and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Company and the Investor hereby agree as follows:

 

SECTION
I

DEFINITIONS

 

As
used in this Agreement, the following terms shall have the following meanings:

 

“Execution
Date” shall have the meaning set forth in the preambles.

 

“Investor”
shall have the meaning set forth in the preambles.

 

“Person”
means a corporation, a limited liability company, an association, a partnership, an organization, a business, an individual, a
governmental or political subdivision thereof or a governmental agency.

 

“Register,”
“Registered,” and “Registration” refer to the Registration effected by preparing and filing
one (1) or more Registration Statements in compliance with the 1933 Act and pursuant to Rule 415 under the 1933 Act or any successor
rule providing for offering securities on a continuous basis (“Rule 415”), and the declaration or ordering
of effectiveness of such Registration Statement(s) by the United States Securities and Exchange Commission (the “SEC”).

 

“Registrable
Securities” means (i) the shares of Common Stock issued or issuable pursuant to the Equity Financing Agreement, and
(ii) any shares of capital stock issued or issuable with respect to such shares of Common Stock, if any, as a result of any stock
split, stock dividend, recapitalization, exchange or similar event or otherwise, which have not been (x) included in the Registration
Statement that has been declared effective by the SEC, or (y) sold under circumstances meeting all of the applicable conditions
of Rule 144 (or any similar provision then in force) under the 1933 Act.

 

    	 	 	 

    	 	 	 

    

 

“Registration
Statement” means the registration statement of the Company filed under the 1933 Act covering the Registrable Securities.

 

“Registered
Offering Transaction Documents” shall mean this Agreementand the Equity Financing Agreement between the Company and
the Investor as of the date hereof.

 

All
capitalized terms used in this Agreement and not otherwise defined herein shall have the same meaning ascribed to them as in the
Equity Financing Agreement.

 

SECTION
II

REGISTRATION

 

2.1
The Company shall, within thirty (30) calendar days upon the date of execution of this Agreement, use its reasonable commercial
efforts to file with the SEC a Registration Statement or Registration Statements (as is necessary) on Form S-1 (or, if such form
is unavailable for such a registration, on such other form as is available for such registration), covering the resale of all
of the Registrable Securities, which Registration Statement(s) shall state that, in accordance with Rule 416 promulgated under
the 1933 Act, such Registration Statement also covers such indeterminate number of additional shares of Common Stock as may become
issuable upon stock splits, stock dividends or similar transactions. The Company shall initially register for resale all of the
Registrable Securities which would be issuable on the date preceding the filing of the Registration Statement based on the closing
bid price of the Company’s Common Stock on such date and the amount reasonably calculated that represents Common Stock issuable
to other parties as set forth in the Equity Financing Agreement except to the extent that the SEC requires the share amount to
be reduced as a condition of effectiveness.

 

2.2
The Company shall use all commercially reasonable efforts to have the Registration Statement(s) declared effective by the SEC
within thirty (30) calendar days, but no more than ninety (90) calendar days after the Company has filed the Registration Statement.

 

2.3
The Company agrees not to include any other securities in the Registration Statement covering the Registrable Securities without
Investor’s prior written consent which Investor may withhold in its sole discretion. Furthermore, the Company agrees that
it will not file any other Registration Statement for other securities, until thirty calendar days after the Registration Statement
for the Registrable Securities is declared effective by the SEC.

 

2.4
Notwithstanding the registration obligations set forth in Section 2.1, if the staff of the SEC (the “Staff”)
or the SEC informs the Company that all of the unregistered Registrable Securities cannot, as a result of the application of Rule
415, be registered for resale as a secondary offering on a single Registration Statement, the Company agrees to promptly (i) inform
the Investor and use its commercially reasonable efforts to file amendments to the Registration Statement as required by the SEC
and/or (ii) withdraw the Registration Statement and file a new registration statement (the “New Registration Statement”),
in either case covering the maximum number of Registrable Securities permitted to be registered by the SEC, on Form S-1 to register
for resale the Registrable Securities as a secondary offering. If the Company amends the Registration Statement or files a New
Registration Statement, as the case may be, under clauses (i) or (ii) above, the Company will use its commercially reasonable
efforts to file with the SEC, as promptly as allowed by the Staff or SEC, one or more registration statements on Form S-1 to register
for resale those Registrable Securities that were not registered for resale on the Registration Statement, as amended, or the
New Registration Statement (each, an “Additional Registration Statement”).

 

    	 	 	 

    	 	 	 

    

 

SECTIONIII

RELATED
OBLIGATIONS

 

At
such time as the Company is obligated to prepare and file the Registration Statement with the SEC pursuant to Section 2.1, the
Company will affect the registration of the Registrable Securities in accordance with the intended method of disposition thereof
and, with respect thereto, the Company shall have the following obligations:

 

3.1
The Company shall use all commercially reasonable efforts to cause such Registration Statement relating to the Registrable Securities
to become effective and shall keep such Registration Statement effective until the earlier to occur of the date on which (A) the
Investor shall have sold all the Registrable Securities; or (B) the Investor has no right to acquire any additional shares of
Common Stock under the Equity Financing Agreement (the “Registration Period”). The Registration Statement (including
any amendments or supplements thereto and prospectuses contained therein) shall not contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein, in light of
the circumstances in which they were made, not misleading. The Company shall use all commercially reasonable efforts to respond
to all SEC comments within ten (10) business days from receipt of such comments by the Company. The Company shall use all commercially
reasonable efforts to cause the Registration Statement relating to the Registrable Securities to become effective no later than
three(3) business days after notice from the SEC that the Registration Statement may be declared effective. The Investor agrees
to provide all information which is required by law to provide to the Company, including the intended method of disposition of
the Registrable Securities, and the Company’s obligations set forth above shall be conditioned on the receipt of such information.

 

3.2
The Company shall prepare and file with the SEC such amendments (including post-effective amendments) and supplements to the Registration
Statement and the prospectus used in connection with such Registration Statement, which prospectus is to be filed pursuant to
Rule 424 promulgated under the 1933 Act, as may be necessary to keep such Registration Statement effective during the Registration
Period, and, during such period, comply with the provisions of the 1933 Act with respect to the disposition of all Registrable
Securities of the Company covered by such Registration Statement until such time as all of such Registrable Securities shall have
been disposed of in accordance with the intended methods of disposition by the Investor thereof as set forth in such Registration
Statement. In the event the number of shares of Common Stock covered by the Registration Statement filed pursuant to this Agreement
is at any time insufficient to cover all of the Registrable Securities, the Company shall amend such Registration Statement, or
file a new Registration Statement (on the short form available therefor, if applicable), or both, so as to cover all of the Registrable
Securities, in each case, as soon as practicable, but in any event within thirty (30) calendar days after the necessity therefor
arises (based on the then Purchase Price of the Common Stock and other relevant factors on which the Company reasonably elects
to rely), assuming the Company has sufficient authorized shares at that time, and if it does not, within thirty (30) calendar
days after such shares are authorized. The Company shall use commercially reasonable efforts to cause such amendment and/or new
Registration Statement to become effective as soon as practicable following the filing thereof.

 

    	 	 	 

    	 	 	 

    

 

3.3
The Company shall make available to the Investor and its legal counsel without charge (i) promptly after the same is prepared
and filed with the SEC at least one (1) copy of such Registration Statement and any amendment(s) thereto, including financial
statements and schedules, all documents incorporated therein by reference and all exhibits, the prospectus included in such Registration
Statement (including each preliminary prospectus) and, with regards to such Registration Statement(s), any correspondence by or
on behalf of the Company to the SEC or the staff of the SEC and any correspondence from the SEC or the staff of the SEC to the
Company or its representatives; (ii) upon the effectiveness of any Registration Statement, the Company shall make available copies
of the prospectus, via EDGAR, included in such Registration Statement and all amendments and supplements thereto; and (iii) such
other documents, including copies of any preliminary or final prospectus, as the Investor may reasonably request from time to
time to facilitate the disposition of the Registrable Securities.

 

3.4
The Company shall use commercially reasonable efforts to (i) register and qualify the Registrable Securities covered by the Registration
Statement under such other securities or “blue sky” laws of such states in the United States as the Investor reasonably
requests; (ii) prepare and file in those jurisdictions, such amendments (including post-effective amendments) and supplements
to such registrations and qualifications as may be necessary to maintain the effectiveness thereof during the Registration Period;
(iii) take such other actions as may be necessary to maintain such registrations and qualifications in effect at all times during
the Registration Period, and (iv) take all other actions reasonably necessary or advisable to qualify the Registrable Securities
for sale in such jurisdictions; provided, however, that the Company shall not be required in connection therewith or as a condition
thereto to (x) qualify to do business in any jurisdiction where it would not otherwise be required to qualify but for this Section
3.4, or (y) subject itself to general taxation in any such jurisdiction. The Company shall promptly notify the Investor of the
receipt by the Company of any notification with respect to the suspension of the registration or qualification of any of the Registrable
Securities for sale under the securities or “blue sky” laws of any jurisdiction in the United States or its receipt
of actual notice of the initiation or threatening of any proceeding for such purpose.

 

3.5
As promptly as practicable after becoming aware of such event, the Company shall notify Investor in writing of the happening of
any event as a result of which the prospectus included in the Registration Statement, as then in effect, includes an untrue statement
of a material fact or omission to state a material fact required to be stated therein or necessary to make the statements therein,
in light of the circumstances under which they were made, not misleading (“Registration Default”) and use all
diligent efforts to promptly prepare a supplement or amendment to such Registration Statement and take any other necessary steps
to cure the Registration Default (which, if such Registration Statement is on Form S-3, may consist of a document to be filed
by the Company with the SEC pursuant to Section 13(a), 13(c), 14 or 15(d) of the 1934 Act (as defined below) and to be incorporated
by reference in the prospectus) to correct such untrue statement or omission, and make available copies of such supplement or
amendment to the Investor. The Company shall also promptly notify the Investor (i) when a prospectus or any prospectus supplement
or post-effective amendment has been filed, and when the Registration Statement or any post-effective amendment has become effective
(the Company will prepare notification of such effectiveness which shall be delivered to the Investor on the same day of such
effectiveness and by overnight mail), additionally, the Company will promptly provide to the Investor, a copy of the effectiveness
order prepared by the SEC once it is received by the Company; (ii) of any request by the SEC for amendments or supplements to
the Registration Statement or related prospectus or related information, (iii) of the Company’s reasonable determination
that a post-effective amendment to the Registration Statement would be appropriate, (iv) in the event the Registration Statement
is no longer effective, or (v) if the Registration Statement is stale as a result of the Company’s failure to timely file
its financials or otherwise

 

3.6
The Company shall use all commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness
of the Registration Statement, or the suspension of the qualification of any of the Registrable Securities for sale in any jurisdiction
and, if such an order or suspension is issued, to obtain the withdrawal of such order or suspension at the earliest possible moment
and to notify the Investor holding Registrable Securities being sold of the issuance of such order and the resolution thereof
or its receipt of actual notice of the initiation or threat of any proceeding concerning the effectiveness of the registration
statement.

 

    	 	 	 

    	 	 	 

    

 

3.7
The Company shall permit the Investor and one (1) legal counsel, designated by the Investor, to review and comment upon the Registration
Statement and all amendments and supplements thereto at least one (1) business day prior to their filing with the SEC. However,
any postponement of a filing of a Registration Statement or any postponement of a request for acceleration or any postponement
of the effective date or effectiveness of a Registration Statement by written request of the Investor (collectively, the “Investor’s
Delay”) shall not act to trigger any penalty of any kind, or any cash amount due or any in-kind amount due the Investor
from the Company under any and all agreements of any nature or kind between the Company and the Investor. The event(s) of an Investor’s
Delay shall act to suspend all obligations of any kind or nature of the Company under any and all agreements of any nature or
kind between the Company and the Investor.

 

3.8
At the request of the Investor, the Company’s counsel shall furnish to the Investor, within two (2) business days, an opinion
letter confirming the effectiveness of the registration statement. Such opinion letter shall be issued as of the date of the effectiveness
of the registration statement, in a form suitable to the Investor.

 

3.9
The Company shall hold in confidence and not make any disclosure of information concerning the Investor unless (i) disclosure
of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information is necessary
to avoid or correct a misstatement or omission in any Registration Statement, or (iii) the release of such information is ordered
pursuant to a subpoena or other final, non-appealable order from a court or governmental body of competent jurisdiction. The Company
agrees that it shall, upon learning that disclosure of such information concerning the Investor is sought in or by a court or
governmental body of competent jurisdiction or through other means, give prompt written notice to the Investor and allow the Investor,
at the Investor’s expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order covering
such information.

 

3.10
The Company shall use all commercially reasonable efforts to maintain designation and quotation of all the Registrable Securities
covered by any Registration Statement on the Principal Market. If, despite the Company’s commercially reasonable efforts,
the Company is unsuccessful in satisfying the preceding sentence, it shall use commercially reasonable efforts to cause all the
Registrable Securities covered by any Registration Statement to be listed on each other national securities exchange and automated
quotation system, if any, on which securities of the same class or series issued by the Company are then listed, if any, if the
listing of such Registrable Securities is then permitted under the rules of such exchange or system. The Company shall pay all
fees and expenses in connection with satisfying its obligation under this Section 3.10.

 

3.11
The Company shall cooperate with the Investor to facilitate the prompt preparation and delivery of the Registrable Securities
to be offered pursuant to the Registration Statement and enable such Registrable Securities to be in such denominations or amounts,
as the case may be, as the Investor may reasonably request.

 

3.12
The Company shall provide a transfer agent for all the Registrable Securities not later than the effective date of the first Registration
Statement filed pursuant hereto.

 

    	 	 	 

    	 	 	 

    

 

3.13
If requested by the Investor, the Company shall (i) as soon as reasonably practical incorporate in a prospectus supplement or
post-effective amendment such information as the Investor reasonably determines should be included therein relating to the sale
and distribution of Registrable Securities, including, without limitation, information with respect to the offering of the Registrable
Securities to be sold in such offering; (ii) make all required filings of such prospectus supplement or post-effective amendment
as soon as reasonably possible after being notified of the matters to be incorporated in such prospectus supplement or post-effective
amendment; and (iii) supplement or make amendments to any Registration Statement if reasonably requested by the Investor.

 

3.14
The Company shall use all commercially reasonable efforts to cause the Registrable Securities covered by the applicable Registration
Statement to be registered with or approved by such other governmental agencies or authorities as may be necessary to facilitate
the disposition of such Registrable Securities.

 

3.15
The Company shall otherwise use all commercially reasonable efforts to comply with all applicable rules and regulations of the
SEC in connection with any registration hereunder.

 

3.16
Within three (3) business day after the Registration Statement is declared effective by the SEC, the Company shall deliver to
the transfer agent for such Registrable Securities, with copies to the Investor, confirmation that such Registration Statement
has been declared effective by the SEC.

 

3.17
The Company shall take all other reasonable actions necessary to expedite and facilitate disposition by the Investor of Registrable
Securities pursuant to the Registration Statement.

 

SECTION
IV

OBLIGATIONS
OF THE INVESTOR

 

4.1
At least five (5) business days prior to the first anticipated filing date of the Registration Statement, the Company shall notify
the Investor in writing of the information the Company requires from the Investor for the Registration Statement. It shall be
a condition precedent to the obligations of the Company to complete the registration pursuant to this Agreement with respect to
the Registrable Securities and the Investor agrees to furnish to the Company that information regarding itself, the Registrable
Securities and the intended method of disposition of the Registrable Securities as shall reasonably be required to effect the
registration of such Registrable Securities and the Investor shall execute such documents in connection with such registration
as the Company may reasonably request. The Investor covenants and agrees that, in connection with any sale of Registrable Securities
by it pursuant to the Registration Statement, it shall comply with the “Plan of Distribution” section of the then
current prospectus relating to such Registration Statement. All information provided to the Company shall be true in all material
respects.

 

4.2
The Investor, by its acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by
the Company in connection with the preparation and filing of any Registration Statement hereunder, unless the Investor has notified
the Company in writing of an election to exclude all of the Investor’s Registrable Securities from such Registration Statement.

 

4.3
The Investor agrees that, upon receipt of written notice from the Company of the happening of any event of the kind described
in Section 3.6 or the first sentence of 3.5, the Investor will immediately discontinue disposition of Registrable Securities pursuant
to any Registration Statement(s) covering such Registrable Securities until the Investor’s receipt of the copies of the
supplemented or amended prospectus contemplated by Section 3.6 or the first sentence of 3.5.

 

    	 	 	 

    	 	 	 

    

 

SECTION
V

EXPENSES
OF REGISTRATION

 

All
legal expenses, other than underwriting discounts and commissions and other than as set forth in the Equity Financing Agreement,
incurred in connection with registrations including comments, filings or qualifications pursuant to Sections 2 and 3, including,
without limitation, all registration, listing and qualifications fees, and printing fees shall be paid by the Company.

 

SECTION
VI

INDEMNIFICATION

 

In
the event any Registrable Securities are included in the Registration Statement under this Agreement:

 

6.1
To the fullest extent permitted by law, the Company, under this Agreement, will, and hereby does, indemnify, hold harmless and
defend the Investor who holds Registrable Securities, the directors, officers, partners, employees, counsel, agents, representatives
of, and each Person, if any, who controls, any Investor within the meaning of the 1933 Act or the Securities Exchange Act of 1934,
as amended (the “1934 Act”) (each, an “Indemnified Person”), against any losses, claims,
damages, liabilities, judgments, fines, penalties, charges, costs, attorneys’ fees, amounts paid in settlement or expenses,
joint or several (collectively, “Claims”), incurred in investigating, preparing or defending any action, claim,
suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any court or governmental, administrative
or other regulatory agency, body or the SEC, whether pending or threatened, whether or not an indemnified party is or may be a
party thereto (“Indemnified Damages”), to which any of them may become subject insofar as such Claims (or actions
or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon: (i) any untrue statement
or alleged untrue statement of a material fact in the Registration Statement or any post-effective amendment thereto or in any
filing made in connection with the qualification of the offering under the securities or other “blue sky” laws of
any jurisdiction in which the Investor has requested in writing that the Company register or qualify the Shares (“Blue
Sky Filing”), or the omission or alleged omission to state a material fact required to be stated therein or necessary
to make the statements therein, in light of the circumstances under which the statements therein were made, not misleading, (ii)
any untrue statement or alleged untrue statement of a material fact contained in the final prospectus (as amended or supplemented,
if the Company files any amendment thereof or supplement thereto with the SEC) or the omission or alleged omission to state therein
any material fact necessary to make the statements made therein, in light of the circumstances under which the statements therein
were made, not misleading, or (iii) any violation or alleged violation by the Company of the 1933 Act, the 1934 Act, any other
law, including, without limitation, any state securities law, or any rule or regulation thereunder relating to the offer or sale
of the Registrable Securities pursuant to the Registration Statement (the matters in the foregoing clauses (i) through (iii) being,
collectively, “Violations”). Subject to the restrictions set forth in Section 6.3 the Company shall reimburse
the Investor and each such controlling person, promptly as such expenses are incurred and are due and payable, for any reasonable
legal fees or other reasonable expenses incurred by them in connection with investigating or defending any such Claim. Notwithstanding
anything to the contrary contained herein, the indemnification agreement contained in this Section 6.1: (i) shall not apply to
a Claim arising out of or based upon a Violation which is due to the inclusion in the Registration Statement of the information
furnished to the Company by any Indemnified Person expressly for use in connection with the preparation of the Registration Statement
or any such amendment thereof or supplement thereto; (ii) shall not be available to the extent such Claim is based on (a) a failure
of the Investor to deliver or to cause to be delivered the prospectus made available by the Company or (b) the Indemnified Person’s
use of an incorrect prospectus despite being promptly advised in advance by the Company in writing not to use such incorrect prospectus;
(iii) any claims based on the manner of sale of the Registrable Securities by the Investor or of the Investor’s failure
to register as a dealer under applicable securities laws; (iv) any omission of the Investor to notify the Company of any material
fact that should be stated in the Registration Statement or prospectus relating to the Investor or the manner of sale; and (v)
any amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the Company, which
consent shall not be unreasonably withheld. Such indemnity shall remain in full force and effect regardless of any investigation
made by or on behalf of the Indemnified Person and shall survive the resale of the Registrable Securities by the Investor pursuant
to the Registration Statement.

 

    	 	 	 

    	 	 	 

    

 

6.2
In connection with any Registration Statement in which Investor is participating, the Investor agrees to severally and jointly
indemnify, hold harmless and defend, to the same extent and in the same manner as is set forth in Section 6.1, the Company, each
of its directors, each of its officers who signs the Registration Statement, each Person, if any, who controls the Company within
the meaning of the 1933 Act or the 1934 Act and the Company’s agents (collectively and together with an Indemnified Person,
an “Indemnified Party”), against any Claim or Indemnified Damages to which any of them may become subject,
under the 1933 Act, the 1934 Act or otherwise, insofar as such Claim or Indemnified Damages arise out of or are based upon any
Violation, in each case to the extent, and only to the extent, that such Violation is due to the inclusion in the Registration
Statement of the written information furnished to the Company by the Investor expressly for use in connection with such Registration
Statement; and, subject to Section 6.3, the Investor will reimburse any legal or other expenses reasonably incurred by them in
connection with investigating or defending any such Claim; provided, however, that the indemnity agreement contained in
this Section 6.2 and the agreement with respect to contribution contained in Section 7 shall not apply to amounts paid in settlement
of any Claim if such settlement is effected without the prior written consent of the Investor, which consent shall not be unreasonably
withheld; provided, further, however, that the Investor shall only be liable under this Section 6.2 for that amount of a Claim
or Indemnified Damages as does not exceed the net proceeds to such Investor as a result of the sale of Registrable Securities
pursuant to such Registration Statement. Such indemnity shall remain in full force and effect regardless of any investigation
made by or on behalf of such Indemnified Party and shall survive the resale of the Registrable Securities by the Investor pursuant
to the Registration Statement. Notwithstanding anything to the contrary contained herein, the indemnification agreement contained
in this Section 6.2 with respect to any preliminary prospectus shall not inure to the benefit of any Indemnified Party if the
untrue statement or omission of material fact contained in the preliminary prospectus were corrected on a timely basis in the
prospectus, as then amended or supplemented. This indemnification provision shall apply separately to each Investor and liability
hereunder shall not be joint and several.

 

6.3
Promptly after receipt by an Indemnified Person or Indemnified Party under this Section 6 of notice of the commencement of any
action or proceeding (including any governmental action or proceeding) involving a Claim, such Indemnified Person or Indemnified
Party shall, if a Claim in respect thereof is to be made against any indemnifying party under this Section 6, deliver to the indemnifying
party a written notice of the commencement thereof, and the indemnifying party shall have the right to participate in, and, to
the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume control of
the defense thereof with counsel mutually satisfactory to the indemnifying party and the Indemnified Person or the Indemnified
Party, as the case may be; provided, however, that an Indemnified Person or Indemnified Party shall have the right to retain its
own counsel with the fees and expenses to be paid by the indemnifying party, if, in the reasonable opinion of counsel retained
by the Indemnified Person or Indemnified Party, the representation by counsel of the Indemnified Person or Indemnified Party and
the indemnifying party would be inappropriate due to actual or potential differing interests between such Indemnified Person or
Indemnified Party and any other party represented by such counsel in such proceeding. The indemnifying party shall pay for only
one (1) separate legal counsel for the Indemnified Persons or the Indemnified Parties, as applicable, and such counsel shall be
selected by the Investor and be reasonably acceptable to the Company, if the Investor is entitled to indemnification hereunder,
or the Company and be reasonable acceptable to the Investor, if the Company is entitled to indemnification hereunder, as applicable.
The Indemnified Party or Indemnified Person shall cooperate fully with the indemnifying party in connection with any negotiation
or defense of any such action or Claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably
available to the Indemnified Party or Indemnified Person which relates to such action or Claim. The indemnifying party shall keep
the Indemnified Party or Indemnified Person fully apprised at all times as to the status of the defense or any settlement negotiations
with respect thereto to the fullest extent permitted by law. No indemnifying party shall be liable for any settlement of any action,
claim or proceeding affected without its written consent, provided, however, that the indemnifying party shall not unreasonably
withhold, delay or condition its consent. No indemnifying party shall, without the consent of the Indemnified Party or Indemnified
Person, consent to entry of any judgment or enter into any settlement or other compromise which does not include as an unconditional
term thereof the giving by the claimant or plaintiff to such Indemnified Party or Indemnified Person of a release from all liability
in respect to such Claim. Following indemnification as provided for hereunder, the indemnifying party shall be subrogated to all
rights of the Indemnified Party or Indemnified Person with respect to all third parties, firms or corporations relating to the
matter for which indemnification has been made. The failure to deliver written notice to the indemnifying party within a reasonable
time of the commencement of any such action shall not relieve such indemnifying party of any liability to the Indemnified Person
or Indemnified Party under this Section 6, except to the extent that the indemnifying party is prejudiced in its ability to defend
such action.

 

6.4
The indemnity agreements contained herein shall be in addition to (I) any cause of action or similar right of the Indemnified
Party or Indemnified Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject
to pursuant to the law.

 

    	 	 	 

    	 	 	 

    

 

SECTIONVII

CONTRIBUTION

 

7.1
To the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make
the maximum contribution with respect to any amounts for which it would otherwise be liable under Section 6 to the fullest extent
permitted by law; provided, however, that: (i) no contribution shall be made under circumstances where the maker would not have
been liable for indemnification under the fault standards set forth in Section 6; (ii) no seller of Registrable Securities guilty
of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution from any
seller of Registrable Securities who was not guilty of fraudulent misrepresentation; and (iii) contribution by any seller of Registrable
Securities shall be limited in amount to the net amount of proceeds received by such seller from the sale of such Registrable
Securities.

 

SECTION
VIII

REPORTS
UNDER THE 1934 ACT

 

8.1
With a view to making available to the Investor the benefits of Rule 144 promulgated under the1933 Act or any other similar rule
or regulation of the SEC that may at any time permit the Investor to sell securities of the Company to the public without registration
(“Rule 144”), provided that the Investor holds any Registrable Securities are eligible for resale under Rule
144, the Company agrees to:

 

	 	a.	make
    and keep adequate current public information available, as those terms are understood and defined in Rule 144;
	 	 	 
	 	b.	file
    with the SEC in a timely manner all reports and other documents required of the Company under the 1933 Act and the 1934 Act
    so long as the Company remains subject to such requirements (it being understood that nothing herein shall limit the Company’s
    obligations under Section 5(c) of the Equity Financing Agreement) and the filing of such reports and other documents is required
    for the applicable provisions of Rule 144; and
	 	 	 
	 	c.	furnish
    to the Investor, promptly upon request, (I) a written statement by the Company that it has complied with the reporting requirements
    of Rule 144, the 1933 Act and the 1934 Act, (ii) a copy of the most recent annual or quarterly report of the Company and such
    other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested to permit
    the Investor to sell such securities pursuant to Rule 144 without registration.

 

SECTION
X

MISCELLANEOUS

 

9.1
NOTICES. Any notices or other communications required or permitted to be given under the terms of this Agreement that must
be in writing will be deemed to have been delivered (i) upon receipt, when delivered personally; (ii) upon receipt, when sent
by email; or (iii) one (1) day after deposit with a nationally recognized overnight delivery service, in each case properly addressed
to the party to receive the same. The addresses for such communications shall be:

 

	If
    to the Company:	 	Clean
        Energy Technologies, Inc.

        2990
        Redhill Ave, Costa Mesa,

        California 92626

        Attn:
        Kambiz Mahdi

	 	 	 
	If
    to the Investor:	 	GHS
        Investments, LLC

        420
        Jericho Turnpike, Suite 102

        Jericho,
        NY 11753

 

Each
party shall provide five (5) business days prior notice to the other party of any change in address, phone number or email address.

 

9.2
NO WAIVERS. Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party
in exercising such right or remedy, shall not operate as a waiver thereof.

 

9.3
NO ASSIGNMENTS. The rights and obligations under this Agreement shall not be assignable.

 

9.4
ENTIRE AGREEMENT/AMENDMENT. This Agreement and the Registered Offering Transaction Documents constitute the entire agreement
among the parties hereto with respect to the subject matter hereof and thereof. There are no restrictions, promises, warranties
or undertakings, other than those set forth or referred to herein and therein. This Agreement and the Registered Offering Transaction
Documents supersede all prior agreements and understandings among the parties hereto with respect to the subject matter hereof
and thereof. The provisions of this Agreement may be amended only with the written consent of the Company and Investor.

 

    	 	 	 

    	 	 	 

    

 

9.5
HEADINGS. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect
the meaning hereof. Whenever required by the context of this Agreement, the singular shall include the plural and masculine shall
include the feminine. This Agreement shall not be construed as if it had been prepared by one of the parties, but rather as if
all the parties had prepared the same.

 

9.6
COUNTERPARTS. This Agreement may be executed in any number of counterparts and by the different signatories hereto on separate
counterparts, each of which, when so executed, shall be deemed an original, but all such counterparts shall constitute but one
and the same instrument. This Agreement may be executed by facsimile transmission, PDF, electronic signature or other similar
electronic means with the same force and effect as if such signature page were an original thereof.

 

9.7
FURTHER ASSURANCES. Each party shall do and perform, or cause to be done and performed, all such further acts and things,
and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably
request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions
contemplated hereby.

 

9.8
SEVERABILITY. In case any provision of this Agreement is held by a court of competent jurisdiction to be excessive in scope
or otherwise invalid or unenforceable, such provision shall be adjusted rather than voided, if possible, so that it is enforceable
to the maximum extent possible, and the validity and enforceability of the remaining provisions of this Agreement will not in
any way be affected or impaired thereby.

 

9.9
Law Governing this Agreement. This Agreement shall be governed by and construed
in accordance with the laws of the State of Nevada without regard to principles of conflicts of laws. Any action brought by either
party against the other concerning the transactions contemplated by this Agreement shall be brought only in the state or federal
courts located in New York City, New York. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction
and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based
upon forum non conveniens. The parties executing this Agreement and other agreements referred to herein or delivered
in connection herewith on behalf of the Company agree to submit to the in personam jurisdiction of such courts and hereby irrevocably
waive trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorney’s
fees and costs. In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid
or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that
it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may
prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement.
Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding
in connection with this Agreement or any other Registered Offering Transaction Documents by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under
this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

 

9.10
NO THIRD PARTY BENEFICIARIES. This Agreement is intended for the benefit of the parties hereto and is not for the benefit
of, nor may any provision hereof be enforced by, any other person, except that the Company acknowledges that the rights of the
Investor may be enforced by its general partner.

 

[Signature
page follows]

 

    	 	 	 

    	 	 	 

    

 

Your
signature on this Signature Page evidences your agreement to be bound by the terms and conditions of the Registration Rights Agreement
as of the date first written above. The undersigned signatory hereby certifies that he has read and understands the Registration
Rights Agreement, and the representations made by the undersigned in this Registration Rights Agreement are true and accurate,
and agrees to be bound by its terms.

 

	 	GHS
    INVESTMENTS, LLC.
	 	 	 
	 	By:
    	 
	 	Name:
    	 
	 	Title:
    	Member
	 	 	 
	 	Clean
    Energy Technologies, Inc.
	 	 	 
	 	By:
    	 
	 	Name:
    	 
	 	Title:	 

 

[SIGNATURE
PAGE OF REGISTRATION RIGHTS AGREEMENT]Exhibit 10.1

 

Execution Version

 

TRANSITION AGREEMENT AND RELEASE

 

THIS TRANSITION AGREEMENT
AND RELEASE (the “Agreement”) is made effective as of the 8th day of July, 2020 (the “Effective Date”),
except as otherwise provide herein, among Omega Healthcare Investors, Inc. (“Parent”), Omega Asset Management
LLC (the “Company”) and Michael D. Ritz (“Executive”). The Parent, the Company and the Executive,
when collectively referred to, are hereinafter identified as the “Parties”.

 

INTRODUCTION

 

Effective August 15, 2020
(the “Transition Effective Date”), Executive will terminate employment from the Company and its “Affiliates,”
which shall mean, for purposes of this Agreement, any person, firm, corporation, partnership, association or entity that, directly
or indirectly or through one or more intermediaries, controls, is controlled by or is under common control with the Company, as
determined by the Company; and the term of the Employment Agreement effective January 1, 2020 among Parent, the Company and
Executive (the “Employment Agreement”) is hereby terminated as of August 15, 2020. In addition, effective
as of August 16, 2020, Parent and Executive shall enter into a Consulting Agreement (the “Consulting Agreement”),
substantially in the form attached as Exhibit A hereto, pursuant to which Executive shall perform business consulting
and business advisory services to Parent and its Affiliates from and after August 16, 2020 through January 1, 2021. As
a result of the level of services expected under the Consulting Agreement, Executive is expected to incur a “Separation
from Service” within the meaning of Section 409A of the Internal Revenue Code on November 2, 2020. Pursuant
to the Employment Agreement, Executive’s termination of employment on August 15, 2020 constitutes a termination of employment
by the Company without “Cause,” as defined in the Employment Agreement, and as a result, Executive is entitled
to certain payments, including prorated incentive compensation. Further, the Company recognizes that due in part to Executive’s
long tenure with the Company and its Affiliates, Executive has unique knowledge, experience and skills, and the Company has a unique
need to engage Executive for an interim period to assist in a smooth transition of his duties and knowledge to other officers.
Accordingly, the Parties desire to enter into this Agreement pursuant to which Executive will receive certain compensation as provided
under the Employment Agreement and certain other prorated incentive compensation and agree to provide transitional consulting services
to the Company from August 16, 2020 through January 1, 2021, in each case upon the terms set forth below.

 

NOW, THEREFORE, the
Parties agree as follows:

 

1.            Terms
and Conditions of Engagement.

 

(a)            Transitional
Employment and Consulting Agreement. The Company and Executive agree that Executive shall remain employed by the Company through
and until August 15, 2020, and Parent and Executive shall enter into the Consulting Agreement, pursuant to which Executive
shall perform such business consulting and business advisory services to Parent and its Affiliates as Parent may require from time
to time from and after August 16, 2020 through January 1, 2021.

 

     

     

    

 

Execution Version

 

2.            Compensation.

 

The Parties hereby
agree that, in consideration for Executive’s promises contained herein, the Executive shall remain employed in his current
role and be paid his base salary at his current rate through and until the Transition Effective Date, as well as continue participation
in any Company benefit plans through and until the Transition Effective Date. Further, in consideration for Executive’s promises
contained herein, and provided that Executive executes this Agreement and returns it to the Company within twenty-one (21) days
of it first being provided to Executive (regardless of whether revisions are made after that date), executes and returns to the
Company the Release Agreement described in Section 2(e) hereof as of August 16, 2020, and does not challenge any
portion of this Agreement, including the Release Agreement, or revoke the Release Agreement within the revocation period provided
therein, and provided that Executive complies with this Agreement, the Employment Agreement and Intellectual Property Agreement
(as defined below), Executive shall be entitled to receive the following amounts (collectively referred to herein as the “Transition
Amounts”), in accordance with Sections 3(b) and 3(c)(1) of the Employment Agreement, in addition to any consulting
fees payable pursuant to the Consulting Agreement:

 

(a)            Benefits.
Following the Transition Effective Date, should Executive elect to receive benefits through COBRA,
Executive shall be entitled to, in accordance with Section 3(c)(i)(B) of the Employment Agreement, payment of
100% of the applicable monthly COBRA premium under the Company’s group health plan for the coverage elected by Executive,
his spouse and his eligible dependents, continued for the lesser of eighteen (18) month or until such COBRA coverage for Executive
(or his spouse or dependents) terminates, which the Company shall pay directly to its group health plan insurer on Executive’s
behalf, provided however, that if such payment would violate applicable law or result in liability or penalties under applicable
law, the Company shall instead pay Executive a taxable amount equal to the amount of each such monthly premium, with one-half of
each monthly premium being added to each of the two monthly installment payments in clause (b) below until all such required
taxable amounts have been paid.

 

(b)            Transition
Payment. Subject to lawful deductions, the gross sum of $853,455, equal to one and one-half times the sum of (i) Executive’s
annual base salary plus (ii) an amount equal to Executive’s “Average Annual Bonus” as defined in the Employment
Agreement (the “Transition Payment”), in accordance with Section 3(c)(i)(A) of the Employment Agreement.
Executive acknowledges and agrees that payment of the Transition Payment shall be made in substantially equal installments not
less frequently than twice per month over the eighteen (18) month period commencing as of the date of his Separation from Service
(expected to be November 2, 2020), provided that, the first payment shall be made sixty (60) days following the date of Separation
form Service (or the first business day following such 60 day period) and shall include all payments accrued from the date of Separation
from Service to the date of the first payment.

 

    	 	2	 

     

    

 

Execution
Version

 

(c)            Equity
Awards. In accordance with Section 3(b) of the Employment Agreement, any rights to, amounts due under or vesting
of any unvested and outstanding equity awards made by Parent or any of its Affiliates to Executive, as specified according to
the terms and conditions of such awards or grants or pursuant to any plans or documents otherwise governing such awards or grants,
provided that, if Executive complies with the Consulting Agreement and does not terminate the Consulting Agreement before January 1,
2021 and the Company does not terminate the Consulting Agreement before January 1, 2021 due to breach by Executive, the prorated
vesting for such awards shall assume that Executive has provided services through January 1, 2021, reflecting the period
of services to be provided by Executive pursuant to the Consulting Agreement, instead of through the date of his termination of
employment by the Company without Cause. For the avoidance of doubt, the amounts of all such outstanding equity awards due to
Executive hereunder are limited to the amounts specified below, but otherwise remain subject to all the terms and conditions of
such equity awards:

 

		(i)	Time-Based Awards. Subject to Sections 2(e), (f) and (g), 3, 4 and 5, Executive shall
vest in a total of 18,439 time-based restricted stock units and profits interest units under the Time-Based Restricted Stock Units
Award Agreements and Time-Based Profits Interest Units Award Agreements issued by Parent effective January 1, 2018, January 1,
2019 and January 1, 2020, with vesting occurring as if Executive had incurred a “Qualifying Termination” (as defined
in such agreements) on January 1, 2021, and which vested units shall be paid when required by the terms of such agreements.
The 18,439 units are comprised of 7,553 units under the January 1, 2018 award agreement, 6,879 units under the January 1,
2019 award agreement and 4,007 units under the January 1, 2020 award agreement.

 

		(ii)	Performance-Based Awards. Subject to Sections 2(e), (f) and (g), 3, 4, and 5, Executive
shall vest in the same number of performance restricted stock units, LTIP units and profits interest units under the agreements
below as if Executive had incurred a “Qualifying Termination” (as defined in such agreements) on January 1, 2021,
which vested units shall be paid when required by the terms of such agreements. The number of vested units under each such agreement
is set forth below, based on the applicable level of performance achieved (threshold, target or high), and where less than the
full performance period under the agreement was served by Executive, a period served by Executive through January 1, 2021,
as well as based on an assumption that a “Change in Control” (as defined in such agreements) does not occur during
the applicable “Performance Period” (as defined in such agreements). If a Change in Control does occur during the applicable
Performance Period, the number of vested units will be determined under the applicable agreement, as modified by this subsection.

 

	 	 	Performance-Based Units	 	 	 	 
	Agreement	 	Already 

Earned	 	 	Threshold	 	 	Target	 	 	High	 	 	% of Period

 Served	 
	January 1, 2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	for 12/31/19 Performance Period end	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	-TSR-Based Performance Profit Interests Units Award Agreement	 	 	22,235	 	 	 	-	 	 	 	-	 	 	 	-	 	 	 	100	%
	-Relative TSR-Based Performance Restricted Stock Unit Award Agreement	 	 	15,583	 	 	 	-	 	 	 	-	 	 	 	-	 	 	 	100	%
	January 1, 2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	for 12/31/20 Performance Period end	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	-TSR-Based LTIP Units Award Agreement	 	 	 	 	 	 	10,506	 	 	 	18,606	 	 	 	39,174	 	 	 	100	%
	- Relative TSR-Based Performance Restricted Stock Unit Award Agreement	 	 	 	 	 	 	4,426	 	 	 	7,997	 	 	 	17,230	 	 	 	100	%
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	January 1, 2019 
for 12/31/21 Performance Period end	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	-TSR-Based Performance Profit Interests Units Award Agreement	 	 	 	 	 	 	5,164	 	 	 	9,128	 	 	 	18,319	 	 	 	66.79	%
	-Relative TSR-Based Performance Profit Interests Units Award Agreement	 	 	 	 	 	 	2,865	 	 	 	5,185	 	 	 	11,205	 	 	 	66.79	%
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	January 1, 2020 
for 12/31/22 Performance Period end	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	-TSR-Based Performance Profit Interests Units Award Agreement	 	 	 	 	 	 	587	 	 	 	3,751	 	 	 	11,146	 	 	 	33.49	%
	-Relative TSR-Based Performance Profit Interests Units Award Agreement	 	 	 	 	 	 	403	 	 	 	2,697	 	 	 	8,662	 	 	 	33.49	%

 

    	 	3	 

     

    

 

Execution
Version

 

(d)            Expenses.
Executive shall be entitled to be reimbursed in accordance with Company policy for reasonable and necessary expenses incurred by
Executive in connection with the performance of Executive’s duties of employment hereunder through the Transition Effective
Date in accordance with the Employment Agreement.

 

(e)            Release
Contingency. The payments to Executive required by Sections 2(a) through 2(c) are contingent upon Executive executing
the Release Agreement attached hereto as Exhibit B (the “Release Agreement”) on August 16,
2020, and delivering it to the Company on August 16, 2020 and not revoking the Release Agreement in accordance with its procedures
within the revocation period provided in the Release Agreement. If Executive fails to timely execute and deliver the Release Agreement
or if Executive revokes the Release Agreement within the revocation period provided in the Release Agreement, this Agreement shall
thereupon automatically terminate, without the requirement of any further action by any party, provided that the provisions of
Sections 4 and 5 hereof shall continue to apply to Executive.

 

(f)            Section 409(a).
All payments provided for in this Agreement are intended to be exempt from Code Section 409A to the maximum extent possible,
and any payments that are subject to Code Section 409A are intended to be compliant therewith, and this Agreement shall be
construed consistent with such intent. While the Company intends that no payment under this Agreement shall be subject to tax under
Code Section 409A, the Company provides no guarantee of tax consequences to Executive and Executive shall be responsible for
Executive’s own taxes. Notwithstanding the foregoing, if the total payments to be paid to Executive hereunder, along with
any other payments to Executive, would result in Executive being subject to the excise tax imposed by Code Section 4999, the
Company shall reduce the aggregate payments to the largest amount which can be paid to Executive without triggering the excise
tax, but only if and to the extent that such reduction would result in Executive retaining larger aggregate after-tax payments.
The determination of the excise tax and the aggregate after-tax payments to be received by Executive will be made by the Company
after consultation with its advisors and in material compliance with applicable law. For this purpose, the Parties agree that the
payments provided for in Section 3(c)(i) of the Employment Agreement are intended to be reasonable compensation for refraining
from performing services after termination of employment (i.e., Executive’s obligations pursuant to Sections 4, 5 and 6)
to the maximum extent possible, and if necessary or desirable, the Company will retain a valuator or consultant to determine the
amount constituting reasonable compensation. If payments are to be reduced, to the extent permissible under Code Section 4999,
payments will be reduced in a manner that maximizes the after-tax economic benefit to Executive and to the extent consistent with
that objective, in the following order of precedence: (A) first, payments will be reduced in order of those with the highest
ratio of value for purposes of the calculation of the parachute payment to projected actual taxable compensation to those with
the lowest such ratio, (B) second, cash payments will be reduced before non-cash payments, and (C) third, payments to
be made latest in time will be reduced first. Any reduction will be made in a manner that is intended to avoid a tax being incurred
under Code Section 409A.

 

    	 	4	 

     

    

 

Execution
Version

 

(g)            Incentive
Recovery Policy. Pursuant to Section 8 of the Employment Agreement, Executive has agreed to be bound by the Company’s
Incentive Compensation Recovery Policy, and that this provision shall survive termination of the Employment Agreement and this
Agreement.

 

3.            Termination.

 

(a)            Termination.
This Agreement may be terminated only: (i) by mutual agreement of the Parties; (ii) as provided in Section 2, as
a result of the failure of Executive to timely execute and deliver the Release Agreement or as a result of Executive revoking the
Release Agreement or (iii) by the Company, as a result of Executive’s material breach of this Agreement or the Employment
Agreement, and if the breach is determined to be curable in the reasonable judgment of the Company, only if the Company has first
given Executive written notice of the breach and a reasonable opportunity to cure the same. Notice of termination shall be given
prior to termination in writing and shall specify the effective date of termination. Except for earned and accrued salary and benefits
and expenses under Sections 2 and 2(d), Executive shall not be entitled to any payments if this Agreement is terminated under clauses
(ii) or (iii) above.

 

(b)            Survival.
The covenants of Executive in Sections 4 and 5 hereof and shall survive the termination of this Agreement and shall not be extinguished
thereby.

 

4.            Restrictive
Covenants.

 

Executive previously
agreed pursuant to Sections 4, 5, 6 and 8 of the Employment Agreement to be subject to certain nondisclosure, cooperation noncompetition,
nonsolicitation and nondisparagement obligations, as well as the Company’s Incentive Compensation Recovery Policy and Intellectual
Property Agreement, each of which survived his termination of employment. Executive confirms that he agrees to comply with his
obligations pursuant to Sections 4, 5, 6 and 8 of the Employment Agreement and that Executive’s compliance with the same
shall be a condition of his receiving the amounts payable under Sections 2(a) through 2(c) hereof.

 

5.            Remedies
and Enforceability.

 

Executive agrees that
the covenants, agreements, and representations contained in Section 4 hereof are of the essence of this Agreement; that each
of such covenants are reasonable and necessary to protect and preserve the interests and properties of the Company and its Affiliates;
that irreparable loss and damage will be suffered by the Company and its Affiliates should Executive breach any of such covenants
and agreements; that each of such covenants and agreements is separate, distinct and severable not only from the other of such
covenants and agreements but also from the other and remaining provisions of this Agreement; that the unenforceability of any such
covenant or agreement shall not affect the validity or enforceability of any other such covenant or agreements or any other provision
or provisions of this Agreement; and that (a) Executive shall forfeit any unpaid compensation under Sections 2(a) through
2(c) if Executive materially breaches a covenant in Section 4 hereof, and (b) the Company and Parent shall be entitled
to seek both temporary and permanent injunctions to prevent a breach or contemplated breach by Executive of any of such covenants
or agreements, in addition to other remedies available to them.

 

    	 	5	 

     

    

 

Execution
Version

 

6.            Notice.

 

All notices, requests,
demands and other communications required hereunder shall be in writing and shall be deemed to have been duly given if delivered
or if mailed, by United States certified or registered mail, prepaid to the party to which the same is directed at the following
addresses (or at such other addresses as shall be given in writing by the Parties to one another):

 

	If to the Company:	 	Omega Healthcare Investors, Inc.
	 	 	303 International Circle, Suite 200
	 	 	Hunt Valley, MD 21030
	 	 	Attn: Chief Legal Officer, General Counsel
	 	 	 
	If to Executive:	 	to the last
address the Company 

has on file for Executive

 

Notices delivered in person shall be effective on the date of
delivery. Notices delivered by mail as aforesaid shall be effective upon the fourth calendar day subsequent to the postmark date
thereof.

 

7.            Miscellaneous.

 

(a)            Assignment.
The rights and obligations of the Company and Parent under this Agreement shall inure to the benefit of the Company’s and
Parent’s successors and assigns. This Agreement may be assigned by the Company or Parent to any legal successor to the Company’s
or Parent’s business or to an entity that purchases all or substantially all of the assets of the Company or Parent, but
not otherwise without the prior written consent of Executive. Executive may not assign this Agreement.

 

(b)            Waiver.
The waiver of any breach of this Agreement by any party shall not be effective unless in writing, and no such waiver shall constitute
the waiver of the same or another breach on a subsequent occasion.

 

(c)            Governing
Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of Maryland. The Parties
agree that any appropriate state or federal court located in Baltimore, Maryland shall have jurisdiction of any case or controversy
arising under or in connection with this Agreement and shall be a proper forum in which to adjudicate such case or controversy.
The Parties consent to the jurisdiction of such courts.

 

    	 	6	 

     

    

 

Execution Version

 

(d)            Entire
Agreement. This Agreement embodies the entire agreement of the Parties hereto relating to the subject matter hereof and supersedes
all oral agreements, and to the extent inconsistent with the terms hereof, all other written agreements. The Parties agree that
the term of the Employment Agreement is terminated effective August 15, 2020 and that the Employment Agreement is hereby terminated
effective August 15, 2020, except as to the terms which survive termination, including without limitation Sections 4 and 5
of the Employment Agreement. As of August 15, 2020, Executive resigns from all positions that he holds with Parent, the Company
and the Affiliates.

 

(e)            Amendment.
This Agreement may not be modified, amended, supplemented or terminated except by a written instrument executed by the Parties
hereto.

 

(f)            Severability.
Each of the covenants and agreements hereinabove contained shall be deemed separate, severable and independent covenants, and in
the event that any covenant shall be declared invalid by any court of competent jurisdiction, such invalidity shall not in any
manner affect or impair the validity or enforceability of any other part or provision of such covenant or of any other covenant
contained herein.

 

(g)            Captions
and Section Headings. Captions and section headings used herein are for convenience only and are not a part of this Agreement
and shall not be used in construing it.

 

    	 	7	 

     

    

 

Execution Version

 

IN WITNESS WHEREOF,
Parent, the Company and Executive have each executed and delivered this Agreement as of the date first shown above.

 

	 	OMEGA HEALTHCARE INVESTORS, INC.
	 	 
	 	By:	/s/ C. Taylor Pickett
	 	 	C Taylor Pickett, Chief Executive Officer
	 	 
	 	OHI ASSET
MANAGEMENT LLC
	 	 
	 	By:	/s/ C. Taylor Pickett
	 	 	C Taylor Pickett, Chief Executive Officer
	 	 
	 	EXECUTIVE
	 	 
	 	By:	/s/ Michael D. Ritz
	 	 	Michael D. Ritz

 

    	 	8	 

     

    

 

Execution Version

 

EXHIBIT B

  

CONSULTING AGREEMENT

 

    	 		 

     

    

 

Execution Version

 

CONSULTING AGREEMENT

 

This Consulting Agreement
(this “Agreement”) is entered to be effective as of August 16, 2020, by and between Omega Healthcare
Investors, Inc. (hereinafter “Omega” or the “Company”) and Michael D. Ritz (hereinafter
 “Consultant”).

 

RECITALS

 

WHEREAS, until
August 15, 2020, Consultant was an officer of Omega, as well as an officer and director of subsidiaries of Omega (collectively,
the “Omega Companies”);

 

WHEREAS, Consultant
has expertise in the area of Omega’s business and is willing to provide consulting services to Omega as set forth herein;
and

 

WHEREAS, Omega
is willing and desires to engage Consultant as an independent contractor, during the Term (as defined below), on the terms and
conditions set forth herein.

 

NOW, THEREFORE,
in consideration of the foregoing and of the mutual promises set forth herein, and intending to be legally bound, the parties
hereto agree as follows:

 

AGREEMENT

 

	1.	Term; Termination; Rights on Termination. 

 

	 	(a)	This Agreement will commence on August 16, 2020, and unless modified by the mutual written agreement of the parties, shall continue until January 1, 2021 (the “Term”). This Agreement may be terminated at any time, with or without cause, by either party with ten (10) days written notice to the other party. The effectiveness of this Agreement is contingent upon Consultant signing on August 16, 2020 and returning on August 16, 2020 that certain Release Agreement and not revoking the Release Agreement within the revocation period provided therein.    

 

	 	(b)	In the event Omega terminates this Agreement during the Term, other than for Consultant’s willful failure or gross negligence in performing the consulting services described on Schedule A hereof (the “Services”), Consultant shall receive from Omega, the monthly Consulting Fee (defined below) then in effect for whatever time period is remaining under the Term. 

 

    	 	2	 

     

    

 

Execution Version

 

	2.	Compensation. 

 

	 	 	Consulting Fee. In consideration of the Services that may be performed by Consultant, Omega agrees to pay Consultant $250 per hour during the Term, subject to the maximum number of hours of services to be provided as described in Section 3(c) below, with monthly payments based on this hourly rate being made on or before the last business day of the month following provision of the Services during the Term of this Agreement based on hours reported by Consultant (“Consulting Fee”). The Company may withhold from any amounts payable with respect to this Agreement such federal, state, local and other taxes as may be required to be withheld, if any, pursuant to any applicable law or regulation. As Consultant is not an employee of any of the Omega Companies, Consultant shall not be permitted to participate in any benefit plans of any of the Omega Companies, except for any right he has to participate in group health plans pursuant to COBRA as a result of a termination of employment.   

 

	3.	Terms and Scope of Services. 

 

	 	(a)	This Agreement shall control and govern all work performed by Consultant. No subsequent variance from, amendment to or modification of this Agreement shall be binding upon the Omega Companies unless it is in writing, expressly provides that it is intended as a variance, amendment or modification and is executed by a fully authorized representative of the Omega Companies. 

 

	 	(b)	The scope of services to be provided hereunder is set forth in “Schedule A” hereto and as further modified and amended under subsequent written agreements between the parties. It is understood that the number of hours of services to be provided hereunder per month will over the portion of the Term (i) ending November 1, 2020 exceed twenty percent (20%) of the time worked by Consultant per month for the Omega Companies averaged over the thirty-six month period before the first day of the Term and (ii) beginning November 2, 2020, not exceed twenty percent (20%) of the time worked by Consultant per month for the Omega Companies averaged over the thirty-six month period before the first day of the Term. 

 

	 	(c)	All travel and out of pocket expenses incurred by Consultant for the benefit of the Omega Companies and in the performance of this agreement that are preapproved in advance by the Company, shall be reimbursed by the Company within ten (10) business days following presentation of valid expense receipts. 

 

	 	(d)	All payments to Consultant hereunder will be reported on Form 1099, and Consultant agrees to accept exclusive liability for the payment of all taxes, contributions for unemployment insurance, old age and survivor’s insurance or annuities, which are based on the fees and expense reimbursements paid to Consultant; and Consultant agrees to reimburse Omega for any of the aforesaid taxes or contributions which by law Omega may be required to pay because of Consultant’s failure to pay the same. 

 

    	 	3	 

     

    

 

Execution Version

 

	 	(e)	The level of Consultant’s services under this Agreement is intended to result in a “separation from service” (as defined under Section 409A of the Internal Revenue Code) occurring on November 2, 2020. Consultant acknowledges that the Company makes no warranties as to any tax consequences regarding payment of the Consulting Fee, and Consultant shall solely be responsible for payment of his own taxes. 

 

	 	(f)	Consultant, as an independent contractor, shall personally perform the services rendered under this Agreement and may not subcontract or delegate his duties to any other party. It is specifically understood and agreed that the manner and means of performing the services required under this Agreement shall be at the sole discretion of the Consultant through use of his independent judgment. Subject to Section 3(b), Consultant shall devote sufficient business time and efforts to the performance of services for the Company to complete the services within the time frames for completion established by the Company. Consultant shall use Consultant’s best efforts in such endeavors. Consultant shall also perform Consultant’s services with a level of care, skill, and diligence that a prudent professional acting in a like capacity and familiar with such matters would use.

 

	 	(g)	Consultant shall have no authority to bind the Omega Companies or any of its officers or employees to any agreement or to make managerial or Consultant decisions that are binding on the Omega Companies. Consultant shall not be subject to the supervision, direction or control of the Omega Companies as to the particular means or methods of performing his services. However, the Omega Companies shall retain the right to review and inspect at any time any part of the work performed by Consultant to assure compliance with appropriate standards and specifications.
	 	 	 
	 	(h)	Upon request or when Consultant’s relationship with the Company terminates, Consultant will immediately deliver to the Company all copies of any and all materials and writings received from, created for, or belonging to the Company including, but not limited to, those which relate to or contain proprietary or confidential information, consistent with the requirements of the Intellectual Property Agreement. 

 

	4.	Entire Agreement. This Agreement contains the entire understanding and agreement between the parties hereto with respect to its subject matter and supersedes any prior or contemporaneous written or oral agreements, representations or warranties between them respecting the subject matter hereof, other than any Transition and Release Agreement entered into between Consultant and Omega. 

 

	5.	Amendment. This Agreement may be amended only by a writing signed by Consultant and by a duly authorized officer of Omega. 

 

	6.	Remedy for Breach. Should either Consultant or Omega resort to legal proceedings to enforce this Agreement, the prevailing party in such legal proceeding shall be awarded, in addition to such other relief as may be granted, attorneys’ fees and costs incurred in connection with such proceeding. 

 

    	 	4	 

     

    

 

Execution Version

 

	7.	Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of Maryland. The parties agree that any appropriate state or federal court located in Baltimore, Maryland shall have jurisdiction of any case or controversy arising under or in connection with this Agreement and shall be a proper forum in which to adjudicate such case or controversy. The parties consent to the jurisdiction of such courts.

  

	8.	
        Duplicate. This Agreement may be
        executed in duplicate originals and is not effective unless signed by both parties.

         

 

 IN WITNESS WHEREOF,
Omega and Consultant have executed this Agreement effective as of the date first written above.

 

	 	 	 	 
	Consultant	 	Omega Healthcare Investors, Inc.
	 	 	 	 
	 	 	By:	           
	 	 	 	 
	 	 	Name:	 
	 	 	 	 
	 	 	Title:	 

 

    	 	5	 

     

    

 

Execution Version

 

SCHEDULE A

 

SCOPE OF SERVICES

 

Consultant shall render such transitional
support services and perform such individual projects as may be requested by the Chief Financial Officer of Omega from time to
time during the Term (the “Services”).

 

It is contemplated that the Consultant
may not be asked to perform any or all of the specified services above during the performance of this Agreement. At the same time,
it is contemplated that the Consultant may be asked to render and perform other valued consulting services to the Company.

 

All services rendered and performance thereof
shall be at the direction of the Chief Financial Officer of Omega.

 

    	 	6	 

     

    

 

Execution Version

 

EXHIBIT B

 

RELEASE AGREEMENT

 

    	 	7	 

     

    

 

Execution Version

 

RELEASE AGREEMENT

 

 

This Agreement (this
 “Agreement”) is made this 16th day of August, 2020, among Omega Healthcare Investors, Inc. (“Parent”),
OHI Asset Management LLC (“Employer”), and Michael D. Ritz (“Employee”).

 

Introduction

 

On August 15,
2020, Employee ceased to be employed as an employee of the Company and an executive officer of Parent and the Company as provided
in that certain Transition and Release Agreement dated July 8, 2020 (the “Transition and Release Agreement”).
Effective August 16, 2020, Employer, Parent and Employee entered into a Consulting Agreement (the “Consulting Agreement”).

 

The Transition and
Release Agreement requires that as a condition to Employee’s right to receive payments under Sections 2(a) through 2(c) thereunder
(the “Transition Amounts”) and as a condition to the effectiveness of the Consulting Agreement, Employee must
execute this Agreement.

 

NOW, THEREFORE,
the parties agree as follows:

 

		1.	Employee has been offered at least twenty-one (21) days from receipt of this Agreement within which
to consider this Agreement, and to become effective this Agreement must be signed by Employee on (and not before or after) August 16,
2020 and returned to Employer on that same date. The effective date of this Agreement shall be the date eight (8) days
after the date on which Employee signs this Agreement (the “Effective Date”). For a period of seven (7) days
following Employee’s execution of this Agreement, Employee may revoke this Agreement, and this Agreement shall not become
effective or enforceable until such seven (7) day period has expired. Employee must communicate revocation of this Agreement
in writing to the Employer no later than seven (7) days following Employee’s execution of this Agreement. Employee’s
signing of the Agreement triggers the commencement of the seven (7) day revocation period.

 

		2.	In exchange for Employee’s execution of this Agreement and in full and complete settlement
of any claims as specifically provided in this Agreement, the Employer will provide Employee with the Transition Amounts in accordance
with and subject to the requirements of the Transition and Release Agreement.

 

		3.	Employee acknowledges and agrees that this Agreement is in compliance with the Age Discrimination
in Employment Act and the Older Workers Benefit Protection Act and that the releases set forth in this Agreement shall be applicable,
without limitation, to any claims brought under these Acts.

 

The release given by Employee
in this Agreement is given solely in exchange for the consideration set forth in Section 2 of this Agreement and such consideration
is in addition to anything of value that Employee was entitled to receive prior to entering into this Agreement.

 

Employee has been advised to
consult an attorney prior to entering into this Agreement, and this provision of the Agreement satisfies the requirement of the
Older Workers Benefit Protection Act that Employee be so advised in writing.

 

    

     

    

 

Execution
Version

 

By entering into this Agreement,
Employee does not waive any rights or claims that may arise after the date this Agreement is executed.

 

		4.	This Agreement shall in no way be construed as an admission by Employer or Parent that it has acted
wrongfully with respect to Employee or any other person or that Employee has any rights whatsoever against Employer or Parent.
Employer and Parent specifically disclaim any liability to or wrongful acts against Employee or any other person on the part of
themselves, their employees or their agents.

 

		5.	As a material inducement to Employer and Parent to enter into this Agreement, Employee hereby irrevocably
releases Employer and Parent and each of the owners, stockholders, predecessors, successors, directors, officers, employees, representatives,
attorneys, affiliates (and agents, directors, officers, employees, representatives and attorneys of such affiliates) of Employer
and Parent and all persons acting by, through, under or in concert with them (collectively, the “Releasees”),
from any and all charges, claims, liabilities, agreements, damages, causes of action, suits, costs, losses, debts and expenses
(including attorneys’ fees and costs actually incurred) of any nature whatsoever, known or unknown, including, but not limited
to, rights arising out of alleged violations of any contracts, express or implied, any covenant of good faith and fair dealing,
express or implied, or any tort, or any legal restrictions on Employer’s right to terminate employees, or any federal, state
or other governmental statute, regulation, or ordinance, including, without limitation: (1) Title VII of the Civil Rights
Act of 1964, as amended by the Civil Rights Act of 1991 (race, color, religion, sex, and national origin discrimination); (2) the
Employee Retirement Income Security Act (“ERISA”); (3) 42 U.S.C. § 1981 (discrimination); (4) the
Americans with Disabilities Act (disability discrimination); (5) the Equal Pay Act; (6) the Age Discrimination in Employment
Act; (7) the Older Workers Benefit Protection Act; (6) Executive Order 11246 (race, color, religion, sex, and national
origin discrimination); (7) Executive Order 11141 (age discrimination); (8) Section 503 of the Rehabilitation Act
of 1973 (disability discrimination); (9) negligence; (10) negligent hiring and/or negligent retention; (11) intentional
or negligent infliction of emotional distress or outrage; (12) defamation; (13) interference with employment; (14) wrongful
discharge; (15) invasion of privacy; or (16) violation of any other legal or contractual duty arising under the laws
of the State of Maryland or the laws of the United States (“Claim” or “Claims”), which Employee
now has, or claims to have, or which Employee at any time heretofore had, or claimed to have, or which Employee at any time hereinafter
may have, or claim to have, against each or any of the Releasees, in each case as to acts or omissions by each or any of the Releasees
up to the time Employee signs this Agreement.

 

		6.	The release in the preceding paragraph of this Agreement does not apply to any rights, payments
or benefits after the effective date of the termination of this Agreement, except for (a) base salary pursuant to Section 2(a) of
the Employment Agreement accrued up to the effective date of termination, (b) any rights to, amounts due under or vesting
of any unvested and outstanding equity awards or grants made by Parent or any of its “Affiliates” (as defined in the
Employment Agreement) to Employee, as specified according to the terms and conditions of such awards or grants or pursuant to any
plans or documents otherwise governing such awards or grants, as modified by Section 2(c) of the Transition and Release
Agreement, (c) pay for accrued but unused vacation that Employer is legally obligated to pay Employee, if any, and only if
Employer is so obligated, (d) any rights as provided under the terms of any other employee benefit and compensation agreements
or plans applicable to Employee, (e) expenses required to be reimbursed pursuant to Section 2(d) of the Employment
Agreement, (f) any rights Employee has under Section 2(h) of the Employment Agreement, and (g) any rights the
Employee may have (if any) to workers compensation benefits.

 

    2

     

    

 

Execution
Version

 

		7.	Employee promises that he will not make statements disparaging to any of the Releasees. Employee
agrees not to make any statements about any of the Releasees to the press (including without limitation any newspaper, magazine,
radio station or television station) or in any social or electronic media outlet without the prior written consent of Employer.
The obligations set forth in the two immediately preceding sentences will expire two years after the Effective Date. Employee will
also cooperate with Employer and its affiliates if Employer requests Employee’s testimony. To the extent practicable and
within the control of Employer, Employer will use reasonable efforts to schedule the timing of Employee’s participation in
any such witness activities in a reasonable manner to take into account Employee’s then current employment, and will pay
the reasonable documented out-of-pocket expenses that Employer pre-approves and that Employee incurs for travel required by Employer
with respect to those activities.

 

		9.	Except as set forth in this Section, Employee agrees not to disclose the existence or terms of
this Agreement to anyone. However, Employee may disclose it to a member of his immediate family or legal or financial advisors
if necessary and on the condition that the family member or advisor similarly does not disclose these terms to anyone. Employee
understands that he will be responsible for any disclosure by a family member or advisor as if he had disclosed it himself. This
restriction does not prohibit Employee’s disclosure of this Agreement or its terms to the extent necessary during a legal
action to enforce this Agreement or to the extent Employee is legally compelled to make a disclosure. However, Employee will notify
Employer promptly upon becoming aware of that legal necessity and provide it with reasonable details of that legal necessity.

 

		10.	Employee has not filed or caused to be filed any lawsuit, complaint or charge with respect to any
Claim he releases in this Agreement. Employee promises never to file or pursue a lawsuit, complaint or charge based on any Claim
released by this Agreement, except that Employee may participate in an investigation or proceeding conducted by an agency of the
United States Government or of any state. Notwithstanding the foregoing, Employee is not prohibited from filing a charge with the
Equal Employment Opportunity Commission but expressly waives his right to personal recovery as a result of such charge. Employee
also has not assigned or transferred any claim he is releasing, nor has he purported to do so.

 

		11.	Employer, Parent and Employee agree that the terms of this Agreement shall be final and binding
and that this Agreement shall be interpreted, enforced and governed under the laws of the State of Maryland. The provisions of
this Agreement can be severed, and if any part of this Agreement is found to be unenforceable, the remainder of this Agreement
will continue to be valid and effective.

 

    3

     

    

 

Execution
Version

 

		12.	This Agreement sets forth the entire agreement among Employer, Parent and Employee and fully supersedes
any and all prior agreements or understandings, written and/or oral, between Employer and Employee pertaining to the subject matter
of this Agreement.

 

		13.	Employee is solely responsible for the payment of any fees incurred as the result of an attorney
reviewing this agreement on behalf of Employee. In any litigation concerning the validity or enforceability of this contract or
in any litigation to enforce the provisions of this contract, the prevailing party shall be entitled to recover reasonable attorneys’
fees and costs, including court costs and expert witness fees and costs.

 

Employee’s signature below indicates
Employee’s understanding and agreement with all of the terms in this Agreement.

 

Employee should take this Agreement home
and carefully consider all of its provisions before signing it. Employee has been provided at least twenty-one (21) days to decide
whether Employee wants to accept and sign this Agreement. Also, if Employee signs this Agreement, Employee will then have an additional
seven (7) days in which to revoke Employee’s acceptance of this Agreement after Employee has signed it.
This Agreement will not be effective or enforceable, nor will any consideration be paid, until after the seven (7) day
revocation period has expired. Again, Employee is free and encouraged to discuss the contents and advisability of signing this
Agreement with an attorney of Employee’s choosing.

 

Employee
should read carefully. This agreement includes a release of all known and unknown claims through the effective date. Employee is
strongly advised to consult with an attorney before executing this document.

 

    4

     

    

 

Execution Version

 

IN WITNESS WHEREOF,
Parent, Employer and Employee have executed this Agreement effective as of the date first written above.

 

	 	OMEGA HEALTHCARE
INVESTORS, INC.
	 	 
	 	By:	 
	 	 	C Taylor Pickett, Chief Executive Officer
	 	 
	 	 
	 	OHI ASSET
MANAGEMENT LLC
	 	 
	 	By:	 
	 	 	C Taylor Pickett, Chief Executive Officer
	 	 
	 	 
	 	EMPLOYEE
	 	 
	 	By:	 
	 	 
	 	 
	 	 
	 	 	Date Signed

 

    5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}]]